Search results
New Frontiers in Cardioprotection
Added:
7 months ago
Review Article
BCIS ACI 2025
Start date:
Jan 29, 2025
End date:
Jan 31, 2025
Event
Added:
8 months ago
Source:
Radcliffe Cardiology
A new whitepaper from the International Cardio-Oncology Society (ICOS) CORE working group outlines a critical roadmap for advancing the cardiovascular care of cancer survivors. Published in the European Heart Journal, the paper reviews the current evidence for cardio-oncology rehabilitation and exercise (CORE) programmes and sets new standards for future research to address significant knowledge…
View more
Added:
5 months ago
Source:
Radcliffe Cardiology
New data from the SEQUOIA-HCM trial suggests that the cardiac myosin inhibitor aficamten provides significant clinical benefits for patients with obstructive hypertrophic cardiomyopathy (oHCM) and mild symptoms, with an efficacy and safety profile comparable to that seen in patients with more advanced symptoms.¹Aficamten is a novel, selective cardiac myosin inhibitor that works by reducing the…
View more
Cardiac Troponins in Kidney Disease
Added:
8 months ago
Review Article
Start date:
Apr 28, 2026
Join leading international and regional experts for an in-depth clinical session focused on the evolving role of semaglutide in the management of cardiometabolic disease. As obesity is increasingly recognised as a chronic, progressive driver of cardiovascular risk, this webinar will explore how to transition from traditional weight-management models to a cardioprotective standard of care tailored…
View more
Added:
8 months ago
Source:
Radcliffe Cardiology
With global temperatures rising and heatwaves becoming more frequent and intense, the impact on public health is a growing concern. A new scientific statement from the European Society of Cardiology (ESC) and several of its constituent bodies highlights the significant risk that extreme heat poses to cardiovascular health, particularly for the elderly and individuals with pre-existing…
View more
Start date:
May 11, 2024
End date:
May 11, 2024
Radcliffe Medical Education is hosting a symposium entitled 'Challenges in ATTR Amyloidosis: An Expert Debate' at theHeart Failure Association (HFA)in Lisbon, PT, on Saturday 11 May 2024 at 12:30 - 13:30 UTC+1.OverviewIn this symposium we join Prof Thibaud Damy (Creteil, FR), Dr Esther González López (Madrid, SP), Dr João R. Agostinho (Lisbon, PT) and Dr Ahmad Masri (Portland, USA) for a…
View more
Added:
8 months ago
Source:
Radcliffe Cardiology
A large-scale, nationwide study from South Korea suggests that vaccination with the live zoster vaccine is associated with a significantly lower risk of various cardiovascular (CV) events in adults aged 50 and older. The findings indicate a protective association that persists for up to 8 years post-vaccination.¹This population-based cohort study analysed data from over 2.2 million individuals…
View more
Added:
5 months ago